Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD)

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Sohal, Sukhwinder S ^a   Walters, Eugene H ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

COPD; Epithelial mesenchymal transition; Large airways; Lung cancer; Small airways; Vimentin

Indexed keywords

UROKINASE RECEPTOR; UVOMORULIN; VIMENTIN;

ANGIOGENESIS; BASEMENT MEMBRANE; BRONCHIOLE; BRONCHIOLITIS OBLITERANS; CANCER SUSCEPTIBILITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PATIENT; CLINICAL FEATURE; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSING ALVEOLITIS; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LUNG CANCER; LUNG CARCINOGENESIS; LUNG FIBROBLAST; PATHOGENESIS; PROTEIN EXPRESSION; FEMALE; IMMUNOLOGY; LUNG; MALE; NOTE; RESPIRATORY TRACT MUCOSA; SMOKING;

EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LUNG; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RESPIRATORY MUCOSA; SMOKING;

EID: 84887104712     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-120     Document Type: Letter

References (19)

1. Wang Q, Wang Y, Zhang Y, Xiao W. The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease. Respir Res 2013, 14:67. 10.1186/1465-9921-14-67, 3700841, 23806081.
2. Sohal SS, Walters EH. Epithelial mesenchymal transition (EMT) in small airways of COPD patients. Thorax 2013, 68(8):783-784. 10.1136/thoraxjnl-2013-203373, 3717724, 23492370.
3. Sohal SS, Ward C, Danial W, Wood-Baker R, Walters EH. Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease. Expert Rev Respir Med 2013, 7(3):275-288. 10.1586/ers.13.26, 23734649.
4. Sohal SS, Soltani A, Weston S, Wood-Baker R, Walters EH. Intermediate filament vimentin and potential role in epithelial mesenchymal transition (EMT). Vimentin Concepts and Molecular Mechanisms 2013, 37-62. New York: Nova Publishers, de Mello RA.
5. Sohal SS, Reid D, Soltani A, Ward C, Weston S, Muller HK, Wood-Baker R, Walters EH. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology 2010, 15(6):930-938. 10.1111/j.1440-1843.2010.01808.x, 20630030.
6. Sohal SS, Reid D, Soltani A, Ward C, Weston S, Muller HK, Wood-Baker R, Walters EH. Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease. Respir Res 2011, 12(1):130. 10.1186/1465-9921-12-130, 3198934, 21970519.
7. Soltani A, Muller HK, Sohal SS, Reid DW, Weston S, Wood-Baker R, Walters EH. Distinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same disease. Histopathology 2012, 60(6):964-970. 10.1111/j.1365-2559.2011.04147.x, 3465784, 22320998.
8. Soltani A, Reid DW, Sohal SS, Wood-Baker R, Weston S, Muller HK, Walters EH. Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study. Respir Res 2010, 11(1):105. 10.1186/1465-9921-11-105, 2918561, 20670454.
9. Soltani A, Sohal SS, Reid D, Weston S, Wood-Baker R, Walters EH. Vessel-associated transforming growth factor-Beta1 (TGF-beta1) is increased in the bronchial reticular basement membrane in COPD and normal smokers. PLoS One 2012, 7(6):e39736. 10.1371/journal.pone.0039736, 3387255, 22768115.
10. Coward WR, Saini G, Jenkins G. The pathogenesis of idiopathic pulmonary fibrosis. Ther Adv Respir Dis 2010, 4(6):367-388. 10.1177/1753465810379801, 20952439.
11. Ward C, Forrest IA, Murphy DM, Johnson GE, Robertson H, Cawston TE, Fisher AJ, Dark JH, Lordan JL, Kirby JA, et al. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax 2005, 60(10):865-871. 10.1136/thx.2005.043026, 1747194, 15972366.
12. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119(6):1420-1428. 10.1172/JCI39104, 2689101, 19487818.
13. Grigoriu BD, Depontieu F, Scherpereel A, Gourcerol D, Devos P, Ouatas T, Lafitte JJ, Copin MC, Tonnel AB, Lassalle P. Endocan expression and relationship with survival in human non-small cell lung cancer. Clin Cancer Res 2006, 12(15):4575-4582. 10.1158/1078-0432.CCR-06-0185, 16899604.
14. Sarrazin SMC, Delmas D, Lassalle P, Delehedde M. Endocan as a biomarker of endothelial dysfunction in cancer. J Cancer Sci Ther 2010, 2(2):047-052.
15. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6(5):392-401. 10.1038/nrc1877, 16572188.
16. Garber K. Epithelial-to-mesenchymal transition is important to metastasis, but questions remain. J Natl Cancer Inst 2008, 100(4):232-233. 239, 10.1093/jnci/djn032, 18270330.
17. Barnes PJ, Adcock IM. Chronic obstructive pulmonary disease and lung cancer: a lethal association. Am J Respir Crit Care Med 2011, 184(8):866-867. 10.1164/rccm.201108-1436ED, 22003145.
18. De Torres JP, Marin JM, Casanova C, Cote C, Carrizo S, Cordoba-Lanus E, Baz-Davila R, Zulueta JJ, Aguirre-Jaime A, Saetta M, et al. Lung cancer in patients with COPD: incidence and predicting factors. Am J Respir Crit Care Med 2011, 184(8):913-919. 10.1164/rccm.201103-0430OC, 21799072.
19. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 2009, 34(2):380-386. 10.1183/09031936.00144208, 19196816.